Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion

J Biol Chem. 2007 Jun 8;282(23):16899-906. doi: 10.1074/jbc.M701701200. Epub 2007 Apr 6.

Abstract

The loss of CD4(+) T cells in HIV-1 infections is hypothesized to be caused by apoptosis of bystander cells mediated by cell surface-expressed HIV-1 Env glycoprotein. However, the mechanism by which Env mediates this process remains controversial. Specifically, the role of HIV-1 gp120 binding to CD4 and CXCR4 versus the fusion process mediated by gp41 remains unresolved. Env-induced apoptosis in bystander cells has been shown to be gp41-dependent and correlates with the redistribution of membrane lipids between Env-expressing cells and target cells (hemifusion). Using a rational mutagenesis approach aimed at targeting Env function via the gp41 subunit, we examined the role of HIV gp41 in bystander apoptosis. A mutation in the fusion domain of gp41 (V513E) resulted in a fusion-defective Env that failed to induce apoptosis. A mutation in the gp41 N-terminal helix (G547D) reduced cell fusion capacity and apoptosis; conversely, an Env mutant with a deletion of the gp41 cytoplasmic tail (Ct Del) enhanced both cell-to-cell fusion and apoptosis. Most significantly, an Env mutant containing a substitution in the loop region of gp41 (D589L) mediated transfer of lipids (hemifusion) to bystander cells but was defective in cell-to-cell and to a lesser degree virus-to-cell fusion. This mutant was still able to induce apoptosis in bystander cells. Hence, we have provided the first direct evidence that gp41-mediated hemifusion is both required and sufficient for induction of apoptosis in bystander cells. These results may help to explain the mechanism of HIV-1 Env-induced T cell depletion.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Apoptosis* / drug effects
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors / pharmacology
  • HIV Envelope Protein gp41 / genetics
  • HIV Envelope Protein gp41 / physiology*
  • HIV-1 / physiology*
  • HeLa Cells
  • Humans
  • Membrane Fusion / physiology*
  • Mutagenesis, Site-Directed
  • Nelfinavir / pharmacology
  • Reverse Transcriptase Inhibitors / pharmacology
  • Virus Replication

Substances

  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • HIV Envelope Protein gp41
  • Reverse Transcriptase Inhibitors
  • Nelfinavir